XML 33 R23.htm IDEA: XBRL DOCUMENT

Related Party Transactions	3 Months Ended
Related Party Transactions	Mar. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	16. Related Party Transactions The Company has related party arrangements with UBI and a number of its affiliated companies listed namely, United Biomedical, Inc., Asia (“UBI-Asia”), UBI Pharma, Inc. (“UBI-P”), United BioPharma, Inc (“UBP”) and UBI IP Holding (“UBI-IP”). As of March 31, 2022 UBI owned 44 % of the Company’s stock. The majority of the voting interests in both UBI and the Company were held by a group of immediate family members, and as such the entities are under common control. Total amounts due to related parties were $ 16.8 million and $ 19.4 million as of March 31, 2022 and December 31, 2021, respectively. Total amounts due from related parties were $ 0.4 million and $ 0.4 million as of March 31, 2022 and December 31, 2021, respectively. Total service fees incurred were $ 0.8 million and $ 8.7 million for the three months ended March 31, 2022 and 2021, respectively. Taiwan Centers for Disease Control Grant (“Taiwan CDC”) UBI-Asia, which is responsible for applying for and managing grants on our behalf under the COVID-19 program, was awarded a grant by the Taiwan CDC for COVID-19 vaccine development. The Company contracted with UBI-Asia to conduct a two-phase study of a COVID-19 vaccine clinical trial in Taiwan. The grant provides that costs incurred to complete the two phases of the clinical trial will be reimbursed based on the achievement of certain milestones as provided in the agreement. The Company provides administrative services to UBI-IP. Under the arrangement, the Company issues vendor payments and provides technical services mostly for legal services on behalf UBI-IP. The Company bills UBI-IP for services based on the costs incurred with no markup. Total related party operating activity, including the activity described above, are as follows (in thousands): March 31, December 31, 2022 2021 Consolidated balance sheet Assets Prepaid expenses and other current assets $ 3,546 $ 3,517 Amounts due from related parties 399 393 Property and equipment, net 299 337 Liabilities Amounts due to related parties 16,787 19,407 Accrued expenses 168 — Three Months Ended March 31, 2022 2021 Operating expenses Research and development Services provided by related parties 784 10,633 Taiwan CDC grant reimbursement from related party — (2,417) General and administrative Services provided by related parties — 507